CoChat

Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1

Open access
Jonchère, Barbara, Vétillard, Alexandra, Toutain, Bertrand, Lam, David, Bernard, Anne Charlotte, Henry, Cécile, Trécesson, Sophie De Carné, Gamelin, Erick, Juin, Philippe, Guette, Catherine, Coqueret, Olivier · 2015 · Oncotarget
Cited by 55

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

// Barbara Jonchère 1 , Alexandra Vétillard 1 , Bertrand Toutain 1 , David Lam 1 , Anne Charlotte Bernard 1 , Cécile Henry 1 , Sophie De Carné Trécesson 2 , Erick Gamelin 1 , Philippe Juin 2,3 , Catherine Guette 1 and Olivier Coqueret 1 1 Paul Papin ICO Cancer Center, INSERM U892, CNRS 6299, Angers University, Angers, France 2 INSERM U892, CNRS 6299, Nantes University, Nantes, France 3 Gauducheau ICO Cancer Center, INSERM U892, CNRS 6299, Nantes, France Correspondence: Olivier Coqueret, email: // Keywords : Chemotherapy, senescence, irinotecan, drug resistance, colorectal cancer Received : September 10, 2014 Accepted : November 06, 2014 Published : November 06, 2014 Abstract Induction of senescence by chemotherapy was initially characterized as a suppressive response that prevents tumor cell proliferation. However, in response to treatment, it is not really known how cells can survive senescence and how irreversible this pathway is. In this study, we analyzed cell escape in response to irinotecan, a first line treatment used in colorectal cancer that induced senescence. We detected subpopulations of cells that adapted to chemotherapy and resumed proliferation. Survival led to the emergence of more transformed cells that induced tumor formation in mice and grew in low adhesion conditions. A significant amount of viable polyploid cells was also generated following irinotecan failure. Markers such as lgr5, CD44, CD133 and ALDH were downregulated in persistent clones, indicating that survival was not associated with an increase in cancer initiating cells. Importantly, malignant cells which resisted senescence relied on survival pathways induced by Mcl-1 signaling and to a lesser extent by Bcl-xL. Depletion of Mcl-1 increased irinotecan efficiency, induced the death of polyploid cells, prevented cell emergence and inhibited growth in low-adhesion conditions. We therefore propose that Mcl-1 targeting should be considered in the future to reduce senescence escape and to improve the treatment of irinotecan-refractory colorectal cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2774

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 55

Metadata

Authors
Jonchère, B., Vétillard, A., Toutain, B., Lam, D., Bernard, A. C., Henry, C., Trécesson, S. D. C., Gamelin, E., Juin, P., Guette, C., & Coqueret, O.
Venue
Oncotarget
Published
2014-11-06
Volume
6
Issue
1
Pages
409-426
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1548190196
Cited by
55
References
11
FWCI
2.14
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1. https://app.cochat.ai/papers/10.18632/oncotarget.2774
The paper
Jonchère, B., Vétillard, A., Toutain, B., Lam, D., Bernard, A. C., Henry, C., Trécesson, S. D. C., Gamelin, E., Juin, P., Guette, C., & Coqueret, O. (2015). Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1. Oncotarget. https://doi.org/10.18632/oncotarget.2774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.